aspirin and spironolactone

aspirin has been researched along with spironolactone in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (39.39)	29.6817
2010's	8 (24.24)	24.3611
2020's	1 (3.03)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ishikawa, Y; Wada, T	1
Bariety, J; Lefkos, N; Marketos, S; Massourides, E; Milliez, P; Papanicolaou, N; Papavassiliou, J	1
Hollifield, JW	1
Cohen, LS	1
Carter, PH; Champion, WL; Currie, TT; Fong, G; Francis, JK; McDonald, IH; Newing, RK; Nunn, IN; Sisson, RN; Sussex, M; Zacharin, RF	1
Ogilvie, RI; Tweeddale, MG	1
Lazarus, L; Sutton, J	1
Nuss, GW; Risley, EA; Van Arman, CG	1
Garcia, HA; Hofmann, LM; Krupnick, MI	1
Trewby, PN	1
Abe, K; Arakawa, K; Asano, T; Kawasaki, T; Okumura, M; Sasaki, H	1
Aguilar, JC; Cleland, J; Cohen-Solal, A; Dietz, R; Eastaugh, J; Follath, F; Freemantle, N; Gavazzi, A; Hobbs, R; Komajda, M; Korewicki, J; Madeira, HC; Mason, J; Moiseyev, VS; Preda, I; Swedberg, K; Van Gilst, WH; Widimsky, J	1
Alexander, S; Anazodo, A; Hussain, K	1
McKelvie, R	2
Bolling, SF; Geltz, A; Spoor, MT	1
Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W	1
Bomback, AS; Klemmer, PJ; Kshirsagar, AV	1
Holman, JR; Jamieson, B; Lin, V	1
Andersen, SE; Edfors, K	1
Chin, KL; Collier, TJ; Krum, H; McMurray, JJ; Pitt, B; Pocock, SJ; Swedberg, K; Turgonyi, E; van Veldhuisen, DJ; Vincent, J; Zannad, F	1
Andersson, C; Andreasen, C; Gislason, GH; Hansen, PW; Køber, L; Steffensen, IE; Torp-Pedersen, C; Weeke, PE	1
Arheden, H; Berg, J; Borgquist, R; Carlsson, M; Jablonowski, R; Mohammad, M; Ostenfeld, E; Solem, K	1

Reviews

7 review(s) available for aspirin and spironolactone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Clinical pharmacology of acetylsalicylic acid. Seminars in thrombosis and hemostasis, 1976, Volume: 2, Issue:3 Topics: Absorption; Aspirin; Blood Platelets; Digestive System; Drug Combinations; Drug Hypersensitivity; Hemostasis; Humans; Kidney; Probenecid; Protein Binding; Salicylates; Spironolactone; Thrombosis; Xylose	1976
Drug-induced peptic ulcer and upper gastrointestinal bleeding. British journal of hospital medicine, 1980, Volume: 23, Issue:2 Topics: Adrenal Cortex Hormones; Alcoholism; Animals; Aspirin; Diuretics; Emepronium; Female; Gastrointestinal Hemorrhage; Humans; Indomethacin; Male; Middle Aged; Peptic Ulcer; Phenylbutazone; Potassium Chloride; Smoking; Spironolactone	1980
Heart failure. Clinical evidence, 2004, Issue:11 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin	2004
Heart failure. Clinical evidence, 2004, Issue:12 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiotonic Agents; Defibrillators, Implantable; Digoxin; Exercise; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Spironolactone; Warfarin	2004
Renal aspirin: will all patients with chronic kidney disease one day take spironolactone? Nature clinical practice. Nephrology, 2009, Volume: 5, Issue:2 Topics: Animals; Aspirin; Humans; Mineralocorticoid Receptor Antagonists; Renal Insufficiency, Chronic; Spironolactone	2009
Clinical Inquiries: Which drugs should post-MI patients routinely receive? The Journal of family practice, 2010, Volume: 59, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Clopidogrel; Eplerenone; Heptanoic Acids; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyrroles; Spironolactone; Ticlopidine	2010

Trials

2 trial(s) available for aspirin and spironolactone

Article	Year
Failure of aspirin to antagonize the antihypertensive effect of spironolactone in low-renin hypertension. Southern medical journal, 1976, Volume: 69, Issue:8 Topics: Adult; Aspirin; Blood Pressure; Blood Urea Nitrogen; Clinical Trials as Topic; Drug Interactions; Female; Humans; Hypertension; Male; Middle Aged; Natriuresis; Placebos; Potassium; Renin; Sodium; Spironolactone	1976
Antagonism of spironolactone-induced natriuresis by aspirin in man. The New England journal of medicine, 1973, Jul-26, Volume: 289, Issue:4 Topics: Administration, Oral; Adult; Aspirin; Clinical Trials as Topic; Fludrocortisone; Humans; Male; Natriuresis; Placebos; Potassium; Sodium; Spironolactone	1973

Other Studies

24 other study(ies) available for aspirin and spironolactone

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome. Japanese circulation journal, 1979, Volume: 43, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Aspirin; Bartter Syndrome; Humans; Hyperaldosteronism; Ibuprofen; Indomethacin; Male; Potassium; Prostaglandins; Sodium; Spironolactone	1979
Interaction between aldosterone and renomedullary prostaglandins. Competitive action between aspirin and spironolactone. Experientia, 1977, Dec-15, Volume: 33, Issue:12 Topics: Adrenalectomy; Aldosterone; Animals; Aspirin; Male; Potassium; Prostaglandins A, Synthetic; Prostaglandins E; Rats; Sodium; Spironolactone	1977
Spironolactone and acute mountain sickness. The Medical journal of Australia, 1976, Jul-31, Volume: 2, Issue:5 Topics: Acute Disease; Adult; Altitude Sickness; Aspirin; Female; Furosemide; Humans; Hypoxia; Male; Middle Aged; Mountaineering; Nepal; Spironolactone; Sports Medicine	1976
Mountain sickness in the Australian alps. The Medical journal of Australia, 1973, Mar-17, Volume: 1, Issue:11 Topics: Adolescent; Adult; Aged; Altitude; Aspirin; Australia; Child; Female; Humans; Hypoxia; Male; Menstruation; Middle Aged; Skiing; Spironolactone	1973
Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat. The Journal of pharmacology and experimental therapeutics, 1973, Volume: 187, Issue:2 Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Body Weight; Chlorpromazine; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Hydrocortisone; Indomethacin; Male; Mycobacterium; Phenytoin; Prednisolone; Rats; Salicylates; Spironolactone; Time Factors	1973
Interactions of spironolactone and hydrochlorothiazide with aspirin in the rat and dog. The Journal of pharmacology and experimental therapeutics, 1972, Volume: 180, Issue:1 Topics: Aldosterone; Animals; Aspirin; Corticosterone; Diuresis; Diuretics; Dogs; Drug Interactions; Female; Hydrochlorothiazide; Kidney; Male; Mineralocorticoids; Natriuresis; Potassium; Rats; Rats, Inbred Strains; Spironolactone	1972
Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist. Endocrinologia japonica, 1980, Volume: 27, Issue:4 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Aldosterone; Aminoglutethimide; Angiotensin II; Aspirin; Bartter Syndrome; Blood Pressure; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Indomethacin; Kallikreins; Male; Middle Aged; Prostaglandins E; Renin; Spironolactone	1980
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. European heart journal, 2003, Volume: 24, Issue:5 Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Calcium Channel Blockers; Cardiac Glycosides; Cardiac Output, Low; Cardiovascular Agents; Europe; Female; Fibrinolytic Agents; Health Surveys; Hospitalization; Humans; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Quality of Health Care; Spironolactone	2003
Interactions of diazoxide with frusemide, spironolactone, and acetylsalicylic acid in a patient with hyperinsulinism of Infancy and Fallot tetralogy. European journal of pediatrics, 2003, Volume: 162, Issue:11 Topics: Aspirin; Diazoxide; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Hyperinsulinism; Infant, Newborn; Risk Assessment; Spironolactone; Tetralogy of Fallot; Treatment Outcome	2003
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation, 2006, Jul-04, Volume: 114, Issue:1 Suppl Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality Therapy; Databases, Factual; Digoxin; Diuretics; Drug Therapy, Combination; Equipment Design; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Milrinone; Mitral Valve; Mitral Valve Insufficiency; Norepinephrine; Pliability; Postoperative Complications; Prospective Studies; Recurrence; Reoperation; Spironolactone; Stroke Volume; Time Factors; Tricuspid Valve Insufficiency; Ultrasonography	2006
[Combination drug therapy after myocardial infarction. Early aldosterone blocking protects risk patients]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Drug Therapy, Combination; Eplerenone; Humans; Hypolipidemic Agents; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Time Factors	2006
Hydroxychloroquine-induced hyperpigmentation: the staining pattern. Journal of cutaneous pathology, 2008, Volume: 35, Issue:12 Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Atorvastatin; Calcium Carbonate; Cardiomyopathy, Restrictive; Citalopram; Connective Tissue Diseases; Diuretics; Female; Furosemide; Glucosamine; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Lupus Erythematosus, Systemic; Magnesium; Metolazone; Middle Aged; Naproxen; Omeprazole; Potassium Chloride; Prednisone; Pyrroles; Selective Serotonin Reuptake Inhibitors; Spironolactone	2008
Assessment of drug treatment quality in two Danish health-care centres. Danish medical bulletin, 2011, Volume: 58, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Denmark; Diuretics; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Qualitative Research; Quality of Health Care; Spironolactone	2011
Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study. European journal of heart failure, 2016, Volume: 18, Issue:9 Topics: Aged; Aspirin; Blood Pressure; Chronic Disease; Drug Interactions; Eplerenone; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Male; Mineralocorticoid Receptor Antagonists; Platelet Aggregation Inhibitors; Potassium; Proportional Hazards Models; Spironolactone; Stroke Volume	2016
Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study. European journal of internal medicine, 2019, Volume: 63 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Calcium Channel Blockers; Denmark; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Mortality; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Registries; Spironolactone; Treatment Outcome	2019
Ventricular longitudinal shortening is an independent predictor of death in heart failure patients with reduced ejection fraction. Scientific reports, 2021, 10-13, Volume: 11, Issue:1 Topics: Aged; Aspirin; Body Mass Index; Cicatrix; Diuretics; Female; Fibrosis; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Spironolactone; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left	2021